GSK hikes price of subsidiary Tesaro's ovarian cancer drug
July 02, 2019 at 14:34 PM EDT
Drug giant GlaxoSmithKline raised the price of cancer drug Zejula by 5 percent this week, bringing the cost for a 30-day supply of 100 milligram Zejula tablets from $6,567 to $6,913.
